Assignee
CUMBERLAND PHARMACEUTICALS INC
US·21 granted patents·44 pending applications·91 citations·filing 2001–2025
Top patents by PatentIndex Score
65 records- 0194US8952065B2Acetylcysteine composition and uses thereofCUMBERLAND PHARMACEUTICALS INC·Filed 2014·Granted Feb 10, 2015·16 cites·9 claims
- 0294US8653061B2Acetylcysteine composition and uses thereofCUMBERLAND PHARMACEUTICALS INC·Filed 2013·Granted Feb 18, 2014·17 cites·10 claims
- 0391US9327028B2Acetylcysteine compositions and methods of use thereofCUMBERLAND PHARMACEUTICALS INC·Filed 2014·Granted May 3, 2016·12 cites·11 claims
- 0491US6727286B2Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acidCUMBERLAND PHARMACEUTICALS INC·Filed 2001·Granted Apr 27, 2004·31 cites·44 claims
- 0590US11806400B2Injectable ibuprofen formulationCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Granted Nov 7, 2023·2 cites·16 claims
- 0688US2025114334A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0785US9693998B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2015·Granted Jul 4, 2017·4 cites·20 claims
- 0884US2024024481A1Injectable ibuprofen formulationCUMBERLAND PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0984US2023381147A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1082US9114068B2Treating patients with intravenous ibuprofenCUMBERLAND PHARMACEUTICALS INC·Filed 2014·Granted Aug 25, 2015·2 cites·14 claims
- 1178US12161632B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2023·Granted Dec 10, 2024·0 cites·10 claims
- 1278US11571412B2Thromboxane receptor antagonists in AERD/asthmaCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Granted Feb 7, 2023·0 cites·4 claims
- 1378US10314824B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2018·Granted Jun 11, 2019·1 cites·9 claims
- 1478US10064845B2Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2017·Granted Sep 4, 2018·2 cites·22 claims
- 1577US2022133696A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1677US2020121793A1Acetylcysteine Compositions and Methods of use ThereofCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1776US9931311B2Treating critically ill patients with intravenous ibuprofenCUMBERLAND PHARMACEUTICALS INC·Filed 2017·Granted Apr 3, 2018·1 cites·7 claims
- 1876US2025049764A1Compositions and Methods of Treating Cardiac Fibrosis with IfetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1976US2022211674A1Thromboxane Receptor Antagonists in AERD/AsthmaCUMBERLAND PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2076US2022218672A1Thromboxane Receptor Antagonists in AERD/AsthmaCUMBERLAND PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2174US8933115B2Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2013·Granted Jan 13, 2015·1 cites·27 claims
- 2274US2020375953A1Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor AntagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2373US9649284B2Treating critically ill patients with intravenous ibuprofenCUMBERLAND PHARMACEUTICALS INC·Filed 2015·Granted May 16, 2017·1 cites·19 claims
- 2473US9138404B2Treating critically ill patients with intravenous ibuprofenCUMBERLAND PHARMACEUTICALS INC·Filed 2014·Granted Sep 22, 2015·1 cites·20 claims
- 2573US2021137895A1Compositions and Methods of Treating Cardiac Fibrosis with IfetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2673US2025235539A1Injectable ibuprofen formulationCUMBERLAND PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2773US2021106561A1Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2872US10925860B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Granted Feb 23, 2021·0 cites·7 claims
- 2972US2020316022A1Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3071US2021015798A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3171US2020171007A1Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor AntagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3270US2020253935A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3369US10583126B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Granted Mar 10, 2020·0 cites·7 claims
- 3469US2019343810A1Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor AntagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3568US2019247365A1Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor AntagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3668US2020113872A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3768US2019269778A1Acetylcysteine Compositions and Methods of use ThereofCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3867US9820966B2Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2014·Granted Nov 21, 2017·0 cites·28 claims
- 3967US2019343809A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4066US2019117621A1Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4165US2018344693A1Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4265US2019117628A1Ifetroban Treatment for Systemic SclerosisCUMBERLAND PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4365US2018055801A1Acetylcysteine Composition and Uses ThereofCUMBERLAND PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 4464US10016399B2Compositions and methods of treating cardiac fibrosis with ifetrobanCUMBERLAND PHARMACEUTICALS INC·Filed 2017·Granted Jul 10, 2018·0 cites·19 claims
- 4564US2018055936A1Acetylcysteine Compositions and Methods of use ThereofCUMBERLAND PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 4664US2019142944A1Injectable ibuprofen formulationCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4763US10456380B2Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonistsCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Granted Oct 29, 2019·0 cites·20 claims
- 4863US2018036282A1Stabilized statin formulationsCUMBERLAND PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 4963US2019151291A1Ifetroban treatment of portal hypertensionCUMBERLAND PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 5062US2017042850A1Acetylcysteine Composition and Uses ThereofCUMBERLAND PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CUMBERLAND PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →